• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有多种包装潜力的高度稳定的L-BC衣壳。

Highly stable L-BC capsids with versatile packing potential.

作者信息

Celitan Enrika, Stanevičienė Ramunė, Servienė Elena, Serva Saulius

机构信息

Laboratory of Nucleic Acid Biochemistry, Department of Biochemistry and Molecular Biology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

Laboratory of Genetics, Nature Research Centre, Vilnius, Lithuania.

出版信息

Front Bioeng Biotechnol. 2024 Sep 25;12:1456453. doi: 10.3389/fbioe.2024.1456453. eCollection 2024.

DOI:10.3389/fbioe.2024.1456453
PMID:39386045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11461329/
Abstract

Virus-like particles (VLPs) are promising nanoscaffolds in development of vaccines and nanodelivery systems. Along with efficient production in various expression systems, they also offer extensive functionalization options. Nevertheless, the ultimate integrity of VLPs is an important burden for the applicability in nanobiotechnology. In this study, we characterize the L-BC VLPs synthesized and purified from and cells. The particles exhibited prominent size stability in buffers within a range of ionic strength conditions, pH environment and presence of magnesium ions during the long-term storage at temperatures up to 37°C. Bacteria-derived particles exhibited alleviated stability in acidic pH values, higher ionic strength and temperature compared to yeast-derived particles. Taking advantage of gene engineering, 120 copies of red fluorescent protein mCherry were successfully encapsulated into both preparations of L-BC VLPs, while passive diffusion enabled encapsulation of antimicrobial peptide nisin into the yeast-derived unmodified VLPs. Our findings indicate that L-BC VLPs generally exhibit high long-term stability under various conditions, while yeast-derived L-BC VLPs are more stable under the elevated temperatures than bacteria-derived particles. Stability studies and encapsulation of particles by different molecules involving alternative strategies delineate the L-BC VLP potential to be developed into versatile nanodelivery system.

摘要

病毒样颗粒(VLPs)是疫苗和纳米递送系统开发中很有前景的纳米支架。除了能在各种表达系统中高效生产外,它们还提供了广泛的功能化选择。然而,VLPs的最终完整性是其在纳米生物技术中应用的一个重要负担。在本研究中,我们对从[具体细胞类型1]和[具体细胞类型2]细胞中合成并纯化的L-BC VLPs进行了表征。在高达37°C的温度下长期储存期间,这些颗粒在一系列离子强度条件、pH环境和镁离子存在的缓冲液中表现出显著的尺寸稳定性。与酵母来源的颗粒相比,细菌来源的颗粒在酸性pH值、较高离子强度和温度下稳定性有所降低。利用基因工程技术,120个红色荧光蛋白mCherry拷贝成功封装到两种L-BC VLPs制剂中,而被动扩散使抗菌肽乳链菌肽能够封装到酵母来源的未修饰VLPs中。我们的研究结果表明,L-BC VLPs在各种条件下通常表现出较高的长期稳定性,而酵母来源的L-BC VLPs在高温下比细菌来源的颗粒更稳定。稳定性研究以及通过不同分子采用替代策略对颗粒进行封装,描绘了L-BC VLPs发展成为通用纳米递送系统的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/8642069d2655/fbioe-12-1456453-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/2c9ab588d7e5/fbioe-12-1456453-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/29d45bdb19a9/fbioe-12-1456453-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/ae52a3acd2fd/fbioe-12-1456453-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/24c0f122d8bd/fbioe-12-1456453-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/f2385180b1ca/fbioe-12-1456453-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/044729513c1f/fbioe-12-1456453-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/5df218a95877/fbioe-12-1456453-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/9df1dbcd0cf7/fbioe-12-1456453-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/436371eeb7ab/fbioe-12-1456453-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/8642069d2655/fbioe-12-1456453-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/2c9ab588d7e5/fbioe-12-1456453-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/29d45bdb19a9/fbioe-12-1456453-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/ae52a3acd2fd/fbioe-12-1456453-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/24c0f122d8bd/fbioe-12-1456453-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/f2385180b1ca/fbioe-12-1456453-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/044729513c1f/fbioe-12-1456453-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/5df218a95877/fbioe-12-1456453-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/9df1dbcd0cf7/fbioe-12-1456453-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/436371eeb7ab/fbioe-12-1456453-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/269b/11461329/8642069d2655/fbioe-12-1456453-g010.jpg

相似文献

1
Highly stable L-BC capsids with versatile packing potential.具有多种包装潜力的高度稳定的L-BC衣壳。
Front Bioeng Biotechnol. 2024 Sep 25;12:1456453. doi: 10.3389/fbioe.2024.1456453. eCollection 2024.
2
Comparison of the size distributions and immunogenicity of human papillomavirus type 16 L1 virus-like particles produced in insect and yeast cells.比较在昆虫细胞和酵母细胞中产生的人乳头瘤病毒 16 型 L1 病毒样颗粒的大小分布和免疫原性。
Arch Pharm Res. 2018 May;41(5):544-553. doi: 10.1007/s12272-018-1024-4. Epub 2018 Apr 10.
3
Yeast as an expression system for producing virus-like particles: what factors do we need to consider?酵母作为生产病毒样颗粒的表达系统:我们需要考虑哪些因素?
Lett Appl Microbiol. 2017 Feb;64(2):111-123. doi: 10.1111/lam.12695. Epub 2016 Dec 14.
4
Virus-Like Particles Produced Using the Brome Mosaic Virus Recombinant Capsid Protein Expressed in a Bacterial System.使用在细菌系统中表达的 Bromus mosaic virus 重组衣壳蛋白生产的病毒样颗粒。
Int J Mol Sci. 2021 Mar 18;22(6):3098. doi: 10.3390/ijms22063098.
5
Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.展示流感病毒蛋白并诱导保护性免疫的禽病毒衣壳发育的结构基础。
J Virol. 2015 Mar;89(5):2563-74. doi: 10.1128/JVI.03025-14. Epub 2014 Dec 17.
6
Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae.在酿酒酵母中产生人和非人多瘤病毒的重组病毒样颗粒。
Intervirology. 2002;45(4-6):308-17. doi: 10.1159/000067922.
7
Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.构建展示针对乙型肝炎病毒表面抗原的具有功能活性中和抗体的多瘤病毒衍生假型病毒样颗粒。
BMC Biotechnol. 2015 Sep 15;15:85. doi: 10.1186/s12896-015-0203-3.
8
Stability of virus-like particles of red-spotted grouper nervous necrosis virus in the aqueous state, and the vaccine potential of lyophilized particles.斜带石斑鱼神经坏死病毒类病毒颗粒在水溶液状态下的稳定性以及冻干颗粒的疫苗潜力。
Biologicals. 2018 Jan;51:25-31. doi: 10.1016/j.biologicals.2017.11.002. Epub 2017 Nov 22.
9
Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs).酵母衍生的重组人乳头瘤病毒病毒样颗粒(HPV VLPs)的拆卸与重新组装。
J Pharm Sci. 2006 Oct;95(10):2195-206. doi: 10.1002/jps.20696.
10
Trans-packaging of human immunodeficiency virus type 1 genome into Gag virus-like particles in Saccharomyces cerevisiae.在酿酒酵母中,将人类免疫缺陷病毒 1 基因组进行包裹,形成 Gag 病毒样颗粒。
Microb Cell Fact. 2013 Mar 26;12:28. doi: 10.1186/1475-2859-12-28.

引用本文的文献

1
Microencapsulation of Monascus Red Pigment Using Saccharomyces cerevisiae Ghosts: Process Optimization and Characterization.利用酿酒酵母空壳对红曲色素进行微囊化:工艺优化与表征
Probiotics Antimicrob Proteins. 2025 Jul 1. doi: 10.1007/s12602-025-10627-x.

本文引用的文献

1
CryoEM and stability analysis of virus-like particles of potyvirus and ipomovirus infecting a common host.冷冻电镜和共同侵染宿主的马铃薯 Y 病毒属和马铃薯 X 病毒属病毒样颗粒的稳定性分析。
Commun Biol. 2023 Apr 19;6(1):433. doi: 10.1038/s42003-023-04799-x.
2
Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery.基于酵母的病毒样颗粒作为疫苗开发与递送的新兴平台
Vaccines (Basel). 2023 Feb 18;11(2):479. doi: 10.3390/vaccines11020479.
3
Virus-like nanoparticles as a theranostic platform for cancer.病毒样纳米颗粒作为癌症的诊疗平台
Front Bioeng Biotechnol. 2023 Jan 12;10:1106767. doi: 10.3389/fbioe.2022.1106767. eCollection 2022.
4
Virus-like Particles as Antiviral Vaccine: Mechanism, Design, and Application.病毒样颗粒作为抗病毒疫苗:作用机制、设计与应用
Biotechnol Bioprocess Eng. 2023;28(1):1-16. doi: 10.1007/s12257-022-0107-8. Epub 2023 Jan 6.
5
Protein cargo encapsulation by virus-like particles: Strategies and applications.病毒样颗粒包封蛋白质货物:策略与应用。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 May-Jun;15(3):e1869. doi: 10.1002/wnan.1869. Epub 2022 Nov 8.
6
Synthesis and Concomitant Assembly of Adeno-Associated Virus-like Particles in .腺相关病毒样颗粒在……中的合成与伴随组装
ACS Synth Biol. 2022 Nov 18;11(11):3601-3607. doi: 10.1021/acssynbio.2c00451. Epub 2022 Oct 24.
7
Virus-like Particles as Nanocarriers for Intracellular Delivery of Biomolecules and Compounds.病毒样颗粒作为生物分子和化合物细胞内递呈的纳米载体。
Viruses. 2022 Aug 28;14(9):1905. doi: 10.3390/v14091905.
8
Structures of L-BC virus and its open particle provide insight into Totivirus capsid assembly.L-BC 病毒及其开放粒子的结构为了解 Totivirus 衣壳组装提供了线索。
Commun Biol. 2022 Aug 20;5(1):847. doi: 10.1038/s42003-022-03793-z.
9
Virus-like Particles: Fundamentals and Biomedical Applications.病毒样颗粒:基础与生物医学应用
Int J Mol Sci. 2022 Aug 2;23(15):8579. doi: 10.3390/ijms23158579.
10
Can Virus-like Particles Be Used as Synergistic Agent in Pest Management?病毒样颗粒能否用作害虫管理中的协同剂?
Viruses. 2022 Apr 30;14(5):943. doi: 10.3390/v14050943.